Non psychoactive cannabis
Pro Research Analysisby 
Searched over 200M research papers
Non-Psychoactive Cannabis: Therapeutic Potential and Applications
Introduction to Non-Psychoactive Cannabinoids
Cannabis sativa, a versatile plant, contains numerous cannabinoids, some of which are psychoactive, like delta-9-tetrahydrocannabinol (THC), and others that are non-psychoactive, such as cannabidiol (CBD) . Unlike THC, CBD does not induce the "high" associated with cannabis use and has garnered significant interest for its potential therapeutic benefits.
Therapeutic Applications of Cannabidiol (CBD)
Gastrointestinal Disorders
CBD and other non-psychoactive cannabinoids have shown promise in treating gastrointestinal disorders. The endocannabinoid system (ECS), which includes cannabinoid receptors and enzymes, is widely distributed in the gastrointestinal tract. Phytocannabinoids like CBD can exert potent effects, particularly under pathological conditions such as inflammation. Research suggests that these compounds could be developed into functional food ingredients and nutraceuticals to support gastrointestinal health.
Mental Health and Antipsychotic Effects
CBD has been studied for its potential antipsychotic properties. Unlike THC, which can induce psychotic symptoms and cognitive impairment, CBD may counteract these effects and even lower the risk of developing cannabis-associated psychosis. Initial clinical studies indicate that CBD could be an effective antipsychotic compound, although the exact mechanisms remain to be fully understood.
Cancer Treatment
Cannabinoids, including CBD, have demonstrated potential in preclinical studies against various cancers such as leukemia, lymphoma, and glioblastoma. These compounds can modulate multiple cancer-related pathways, inhibit cell growth, and induce apoptosis selectively in tumor cells. Additionally, cannabinoid-based products like dronabinol and nabiximols are approved for managing symptoms such as anorexia and pain in cancer patients.
Comparative Effects of CBD and THC
Cognitive and Driving Performance
Studies comparing the effects of THC-dominant cannabis and cannabis with equivalent concentrations of THC and CBD have shown that both types can impair cognitive and driving performance. Interestingly, cannabis containing both THC and CBD may not be less impairing than THC-dominant cannabis and, in some cases, may exacerbate THC-induced impairment. This suggests that while CBD has therapeutic potential, its presence does not necessarily mitigate the adverse effects of THC.
Psychoactivity and Modulation
CBD is not psychoactive but plays a modulating role on the psychoactive effects of THC. While THC is the primary contributor to cannabis psychoactivity, CBD can influence the overall effects of cannabis, potentially reducing some of the negative impacts associated with THC.
Conclusion
Non-psychoactive cannabinoids, particularly CBD, offer a range of therapeutic benefits, from treating gastrointestinal disorders to potential antipsychotic and anticancer effects. However, the interaction between CBD and THC is complex, and while CBD can modulate the effects of THC, it does not eliminate the impairments associated with THC use. As research continues, the development of non-psychoactive cannabinoid-based therapies holds promise for various medical conditions, emphasizing the need for further studies to fully understand their mechanisms and optimize their use.
Sources and full results
Most relevant research papers on this topic